MS Hirsch, JC Kaplan - Annals of internal medicine, 1985 - Am Coll Physicians Human T-lymphotropic virus type III is susceptible to attack at various sites
during its replicative cycle. Inhibitors of reverse transcriptase activity,
including suramin, antimoniotungstate (HPA-23), and trisodium ... Cited by 21 - Related articles - All 5 versions
HC LANE, AS FAUCI - Annals of internal medicine, 1985 - Am Coll Physicians Although effective therapies are available for many of the infections and tumors
that occur in patients with the acquired immunodeficiency syndrome (AIDS), no
therapy exists for the underlying immunodeficiency. Three approaches used ... Cited by 40 - Related articles - All 3 versions
P Chandra, LK Steel, U Ebener, M Woltersdorf … - Pharmacol. Ther. Part A, 1977 - crosbi.znanstvenici.hr An active intervention of oncogenesis by RNA tumor viruses can be achieved
immunologically, as well as chemotherapeutically. The immunological approach is
limited, however, to intervention with cell-virus recognition, and the ... Cited by 9 - Related articles - Cached
L Resnick, PD Markham, K Veren, SZ … - The Journal of infectious diseases, 1986 - jstor.org The discovery of HTLV-III/LAV (a cytopathic member of the human T lymphotropic
retrovirus [HTLV] family) and its identification as the etiologic agent of AIDS
and its prodromes now permits the consideration of therapy directed against ... Cited by 11 - Related articles - All 3 versions
W Rozenbaum, D Dormont, B Spire, E Vilmer, M … - Lancet, 1985 - popline.org The antiviral activity of HPA 23 was assessed by viral isolation studies in the
lymphocytes of 4 patients with acquired immunodeficiency syndrome (AIDS) or
related syndromes. HPA 23 reduced lymphadenopathy-associated virus (LAV) in ... Cited by 65 - Related articles - Cached - All 5 versions
B Oberg - Journal of antimicrobial chemotherapy(Print), 1986 - cat.inist.fr Antiviral chemotherapy against HTLV-III/LAV infections. B OBERG Journal of
antimicrobial chemotherapy(Print) 17:55, 549-552, Oxford University Press, 1986. ... Cited by 4 - Related articles - All 2 versions
JC Beldekas, EM Levy, P Black, G Von Krogh … - Lancet, 1986 - popline.org The drug foscarnet (trisodium phosphonoformate) has been shown to be effective
against human T-lymphotropic virus type III (HTLV-III) in a dose-dependent
manner when added to infected H-9 cultures. The in vivo effect of foscarnet ... Cited by 6 - Related articles - Cached - All 3 versions
PL Meroni, W Barcellini, C Messina, G De … - Journal of clinical & laboratory immunology, 1982 - ncbi.nlm.nih.gov Peripheral blood mononuclear cells from patients with essential mixed
cryoglobulinemia were investigated for the ability to induce suppressor cell
activity (SCA) following in vitro exposure to Concanavalin A (Con A). The ... Cited by 6 - Related articles
E De Clercq, J Balzarini - Antiviral research, 1985 - ncbi.nlm.nih.gov 1: Antiviral Res. 1985;Suppl 1:89-94. In search of specific inhibitors of
retrovirus replication. De Clercq E, Balzarini J. Publication ... Cited by 8 - Related articles
